Idolo Biotechnology LLC is categorized under Research and Development Laboratories in San Francisco, CA .
Idolo Biotechnology LLC was established in 0, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact William J Rutter at the company’s single location by writing to 1700 Owens St # 515, San Francisco, California CA 94158 or by phoning (415) 554-8170. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Idolo Biotechnology LLC |
| Contact Person: | William J Rutter |
| Address: | 1700 Owens St # 515, San Francisco, California 94158 |
| Phone Number: | (415) 554-8170 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research and Development Laboratories |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Idolo Biotechnology LLC was started in 0 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact William J Rutter for inquiries that concern Idolo Biotechnology LLC by calling the company number (415) 554-8170, as your correspondence is most welcome. Additionally, the physical location of the single location of Idolo Biotechnology LLC can be found at the coordinates 37.767656,-122.394082 as well as the street address 1700 Owens St # 515 in San Francisco, California 94158.
For its online presence, you may visit Idolo Biotechnology LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.